共 50 条
- [4] Once Daily High Dose Regimens of GLPG0634 in Healthy Volunteers Are Safe and Provide Continuous Inhibition of JAK1 but Not JAK2. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S573 - S573
- [5] Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases JOURNAL OF IMMUNOLOGY, 2013, 191 (07): : 3568 - 3577
- [6] An Active Metabolite Contributes To The Pharmacodynamics and Efficacy Of GLPG0634, a Selective JAK1 Inhibitor ARTHRITIS AND RHEUMATISM, 2013, 65 : S765 - S765
- [9] GLPG0634, the first selective JAK1 inhibitor, shows strong activity in the mouse DSS-colitis model JOURNAL OF CROHNS & COLITIS, 2014, 8 : S92 - S92
- [10] Analysis Of The JAK1 Selectivity Of GLPG0634 and Its Main Metabolite In Different Species, Healthy Volunteers and Rheumatoid Arthritis Patients ARTHRITIS AND RHEUMATISM, 2013, 65 : S209 - S210